Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations

References

• Zuliani G Morieri ML Volpato S Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study Atherosclerosis 2013 226 1 201 207 23141584
   PubMed Web of Science ®Google Scholar
• Virella G Lopes-Virella MF The pathogenic role of the adaptive immune response to modified LDL in diabetes Front Endocrinol (Lausanne) 2012 3 76 22715334
   PubMedGoogle Scholar
• Perrin-Cocon L Diaz O Andre P Lotteau V Modified lipoproteins provide lipids that modulate dendritic cell immune function Biochimie 2013 95 1 103 108 22959067
   PubMed Web of Science ®Google Scholar
• Kaplan M Aviram M Hayek T Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy Pharmacol Ther 2012 136 2 175 185 22890211
   PubMed Web of Science ®Google Scholar
• El-Bassiouni EA Helmy MH El-Zoghby SM El-Nabi Kamel MA Hosny RM Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients Br J Biomed Sci 2007 64 3 109 116 17910279
   PubMed Web of Science ®Google Scholar
• Yang H Mohamed AS Zhou SH Oxidized low density lipoprotein, stem cells, and atherosclerosis Lipids Health Dis 2012 11 85 22747902
   PubMed Web of Science ®Google Scholar
• Wegner M Piorunska-Stolzmann M Araszkiewicz A Does oxidized LDL contribute to atherosclerotic plaque formation and microvascular complications in patients with type 1 diabetes? Clin Biochem 2012 45 18 1620 1623 22960236
   PubMed Web of Science ®Google Scholar
• Shimada K Mokuno H Matsunaga E Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease Diabetes Care 2004 27 3 843 844 14988319
   PubMed Web of Science ®Google Scholar
• Garrido-Sanchez L Cardona F Garcia-Fuentes E Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus Eur J Clin Invest 2008 38 9 615 621 18837736
   PubMed Web of Science ®Google Scholar
• Jiang X Yang Z Chandrakala AN Pressley D Parthasarathy S Oxidized low density lipoproteins – do we know enough about them? Cardiovasc Drugs Ther 2011 25 5 367 377 21845368
   PubMed Web of Science ®Google Scholar
• Parthasarathy S Raghavamenon A Garelnabi MO Santanam N Oxidized low-density lipoprotein Methods Mol Biol 2010 610 403 417 20013192
   PubMedGoogle Scholar
• Lopes-Virella MF Virella G Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis J Atheroscler Thromb 2013 20 10 743 754 23965492
   PubMed Web of Science ®Google Scholar
• Virella G Carter RE Saad A Crosswell EG Game BA Lopes-Virella MF Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy Clin Immunol 2008 127 3 394 400 18533284
   PubMed Web of Science ®Google Scholar
• Lopes-Virella MF Virella G Clinical significance of the humoral immune response to modified LDL Clin Immunol 2010 134 1 55 65 19427818
   PubMed Web of Science ®Google Scholar
• Hunt KJ Baker N Cleary P Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes Atherosclerosis 2013 231 2 315 322 24267245
   PubMed Web of Science ®Google Scholar
• Crisby M Henareh L Agewall S Relationship between oxidized LDL, IgM, and IgG Autoantibodies to oxLDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction Angiology 11 27 2013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Lopes-Virella MF Baker NL Hunt KJ Lachin J Nathan D Virella G Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes Atherosclerosis 2011 214 2 462 467 21156319
   PubMed Web of Science ®Google Scholar
• Santos AO Fonseca FA Fischer SM High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation Clin Chim Acta 2009 406 1–2 113 118 19523463
   PubMed Web of Science ®Google Scholar
• Garrido-Sanchez L Garcia-Pinilla JM Jimenez-Navarro M Reduced levels of anti-MDA LDL antibodies in patients with carbohydrate metabolism disorders Clin Lab 2011 57 11–12 901 907 22239020
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y Wu R Dearing LD Matsuura E Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 2004 110 17 2552 2558 15505108
   PubMed Web of Science ®Google Scholar
• Rathmann W Giani G Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 10 2568 2569 15451946
   PubMed Web of Science ®Google Scholar
• Du M Wu M Fu D Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy? Diabetologia 2013 56 10 2318 2328 23842729
   PubMed Web of Science ®Google Scholar
• Hogan P Dall T Nikolov P Economic costs of diabetes in the US in 2002 Diabetes Care 2003 26 3 917 932 12610059
   PubMed Web of Science ®Google Scholar
• Rajkovic N Zamaklar M Lalic K OP3: oxidized LDL as residual lipid risk marker in type 2 diabetes Diabetes Metab 2012 38 Suppl 5 S98 S99
   Google Scholar
• Cicero AF Reggi A Tartagni E Grandi E D’Addato S Borghi C Brisighella Heart Study Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella Heart Study Adv Clin Exp Med 2013 22 1 69 76 23468264
   PubMed Web of Science ®Google Scholar
• Genuth S Alberti KG Bennett P Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 2003 26 11 3160 3167 14578255
   PubMed Web of Science ®Google Scholar
• Holvoet P Macy E Landeloos M Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL Clin Chem 2006 52 4 760 764 16497937
   PubMed Web of Science ®Google Scholar
• Craig WY Poulin SE Nelson CP Ritchie RF ELISA of IgG antibody to oxidized low-density lipoprotein: effects of blocking buffer and method of data expression Clin Chem 1994 40 6 882 888 8087982
   PubMed Web of Science ®Google Scholar
• Matsumoto H Uchino M Kato M Evaluation of haemoglobin A1c measurement by an enzymatic method using an automated analyser that has an on-board haemolysis system Ann Clin Biochem 2013 50 Pt 5 443 449 23897101
   PubMed Web of Science ®Google Scholar
• Luca AC Iordache C Obesity – a risk factor for cardiovascular diseases Rev Med Chir Soc Med Nat Iasi 2013 117 1 65 71 24505894
   PubMedGoogle Scholar
• Beck J Ferrucci L Sun K Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women Nutrition 2008 24 10 964 968 18585897
   PubMed Web of Science ®Google Scholar
• Tumova E Sun W Jones PH Vrablik M Ballantyne CM Hoogeveen RC The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals J Obes 2013 2013 729515 24455214
   PubMedGoogle Scholar
• Sanches LB da Silva IT Paz AF Anti-oxLDL autoantibodies and their correlation with lipid profile and nutritional status in adolescents J Pediatr (Rio J) 2008 84 3 258 263 18535732
   PubMed Web of Science ®Google Scholar